Hepatitis A : News
Print
Email
SaveHealthline's Premium Tools
Healthline Part D Plan Selector
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
|
... company Peregrine Pharmaceuticals (NASDAQ: PPHM), developing monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection, announced today (7 October) that patient enrolment in the first stage of Phase II study of ...
|
|
A new study finds that nearly one-third of teenagers are not up-to-date with their immunizations, including vaccinations for measles-mumps-rubella, hepatitis B, tetanus and diphtheria.
|
|
... their measles-mumps-rubella (MMR) immunizations. Seventy-four percent of the adolescents were up to date on their hepatitis B immunizations, while 84 percent were up to date for tetanus-diphtheria immunizations. The hepatitis B and MMR coverage ...
|
|
... should see a physician or visit a walk-in clinic and ask for a blood test for Human Immunodeficiency Virus (HIV), hepatitis B and hepatitis C.a At this time, there is no evidence of transmission of these infectious diseases, but there is always a ...
|
|
Main Category: Liver Disease / Hepatitis Also Included In: Clinical Trials / Drug Trials Article Date: 07 Oct 2008 - 9:00 PDT Salix Pharmaceuticals, Ltd.
|
|
... that vaccines can now protect against include whooping cough, German measles, polio, diphtheria, tetanus, hepatitis, and mumps. Some vaccines induce prolonged or even life-long immunity to certain diseases and can be given just once. But others only ...
|
|
... omplish fully and always. One can't just have sex, with just anybody. This is dangerous, because it could lead, to Hepatitis C and then, one is stuck, with the use of, condoms, till they die. I find loose sex, incredibly stupid and self destructive.
|
|
... announced shortly. About Locteron Locteron is designed to be a best-in-class therapeutic for patients with chronic hepatitis C, with the potential to induce less side effects, improve patient compliance and provide a more convenient ...
|
|
... candidate is Locteron, a controlled-release interferon alfa designed to improve patient care in the treatment of hepatitis C through a more favorable side-effect profile and dosing convenience compared to existing pegylated interferon products. It ...
|
|
... Heptatits, is one example. This is a cirrhosis of the liver in a patient who is not an alcoholic and does not have Hepatitis C. A fatty liver causes the disease that is the fourth cause for liver transplantation.
|
|
... tumor lysis syndrome (TLS), severe mucocutaneous reactions, and progressive multifocal leukoencephalopathy (PML). Hepatitis B reactivation with fulminant hepatitis, other viral infections, cardiovascular events, renal toxicity, and bowel obstruction ...
|
|
... insurance, and discovered when trying to get his own private-pay plan, no one would cover him because he had Hepatitis C. When he learned his surgery, a cholecystectomy, would run at least $20,000, he hit the internet to learn more about medical ...
|
|
... a reputation for publishing first class research on esophageal cancer, gastric cancer, liver cancer, viral hepatitis, colorectal cancer, and H pylori infection and provides a forum for both clinicians and scientists. WJG has been indexed and ...
|
|
... were carrying the e-coli bacteria. A host of other bacteria were also found on the purses, the most notable being hepatitis. The researchers recommend that woman wipe the bottom of their purse once a day and to be very cautious of where they place ...
|
|
... of teens weren't up-to-date on their measles-mumps-rubella vaccination, another quarter were missing out on their hepatitis B protection, and 16 percent weren't fully immunized against tetanus and diphtheria. "We found that adolescent immunization ...
|
 |
 |
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2008 Healthline Networks, Inc. All rights reserved.